To investigate the clinicopathological characteristics of FASN expression in CRC tissues, CRC patients were divided into a group with high FASN expression (IHC score > 6) and a group with low FASN expression (IHC score ≤ 6). This evidence concerns the gene FASN and colorectal carcinoma.